EUVIMEDEUVIMED entdecken
LeserbriefFallbericht

Palbociclib and chemotherapy followed by blinatumomab consolidation to CAR‐T cell therapy in KMT2A‐ rearranged, therapy‐related acute lymphoblastic leukemia

Sanila Sarkar, Emily Rav iD, Lea Stitzlein, Amber Gibson iD, David McCall iD, Cesar Nunez, Michael Roth iD, Dristhi Ragoonanan iD, Jeremy Connors, Cynthia E Herzog, Branko Cuglievan, Miriam B Garcia iD

Pediatric Blood & Cancer · 2024

DOI: 10.1002/pbc.30964 ↗

Kurz gefasst

Leserbrief in der Zeitschrift Pediatric Blood & Cancer, 2024. Verfasst von Sanila Sarkar und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatric Hematology Oncology, University Hospitals Rainbow Babies and Children, Cleveland, Ohio, USA. Hauptthemen laut MEDLINE: Antibodies, Bispecific, Myeloid-Lymphoid Leukemia Protein, Histone-Lysine N-Methyltransferase, Precursor Cell Lymphoblastic Leukemia-Lymphoma. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 18 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antibodies, BispecificMyeloid-Lymphoid Leukemia ProteinHistone-Lysine N-MethyltransferasePrecursor Cell Lymphoblastic Leukemia-LymphomaImmunotherapy, AdoptivePiperazinesPyridinesAntineoplastic Combined Chemotherapy ProtocolsHumansMaleFemaleGene RearrangementAcrylamidesChildNeoplasms, Second Primary

Substanzen

blinatumomabAntibodies, BispecificMyeloid-Lymphoid Leukemia ProteinKMT2A protein, humanHistone-Lysine N-MethyltransferasepalbociclibPiperazinesPyridinesAcrylamides

Autor:innen und Institutionen

  • Department of Pediatric Hematology Oncology, University Hospitals Rainbow Babies and Children, Cleveland, Ohio, USA.
  • Department of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Department of Pediatrics Research, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

ORCID-Profile: Emily Rav, Amber Gibson, David McCall, Michael Roth, Dristhi Ragoonanan, Miriam B Garcia

Zitieren

APA

Sarkar, S., Rav, E., Stitzlein, L., Gibson, A., McCall, D., Nunez, C., Roth, M., Ragoonanan, D., Connors, J., Herzog, C. E., Cuglievan, B., & Garcia, M. B. (2024). Palbociclib and chemotherapy followed by blinatumomab consolidation to CAR‐T cell therapy in KMT2A‐ rearranged, therapy‐related acute lymphoblastic leukemia. Pediatric Blood & Cancer. https://doi.org/10.1002/pbc.30964

Vancouver

Sarkar S, Rav E, Stitzlein L, Gibson A, McCall D, Nunez C, et al. Palbociclib and chemotherapy followed by blinatumomab consolidation to CAR‐T cell therapy in KMT2A‐ rearranged, therapy‐related acute lymphoblastic leukemia. Pediatric Blood & Cancer. 2024. doi:10.1002/pbc.30964

BibTeX
@article{Sarkar2024,
  author = {Sarkar, Sanila and Rav, Emily and Stitzlein, Lea and Gibson, Amber and McCall, David and Nunez, Cesar and Roth, Michael and Ragoonanan, Dristhi and Connors, Jeremy and Herzog, Cynthia E and Cuglievan, Branko and Garcia, Miriam B},
  title = {Palbociclib and chemotherapy followed by blinatumomab consolidation to CAR‐T cell therapy in KMT2A‐ rearranged, therapy‐related acute lymphoblastic leukemia},
  journal = {Pediatric Blood & Cancer},
  year = {2024},
  doi = {10.1002/pbc.30964}
}
Kostenlos starten →